AzTrials
AzTrials

Biliary Tract DiseasesNCT03879720

Comparison of Standard and Endoscope Assisted Endotracheal Intubation

A study testing Endoscope assisted endotracheal intubation [EAEI] in people with Biliary Tract Diseases and Pancreatic Diseases, run by Stanford University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparison of standard endotracheal intubation and endoscopist-facilitated endotracheal intubation Read more about this study

Who is it for?
Any age
Conditions the study is for
Biliary Tract Diseases, Pancreatic Diseases
What is being tested?
Endoscope assisted endotracheal intubation [EAEI]
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
30 Aug 2018to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients undergoing ERCP at Stanford University Medical Center

Who cannot join

  • Unable to consent
  • Contra-indication to general anesthesia

Trial locations and contacts

1 site in 1 country.

Subhas Banerjee contact

650-723-2623

sbanerje@stanford.edu

United States1 site, 1 recruiting
  • Stanford University Medical Center

    Stanford, California, 94304

    Subhas Banerjee, 650-723-2623, sbanerje@stanford.edu

    Recruiting

Other trials in United States

About this study

Official title: Comparison of Standard Endotracheal Intubation [SEI] and Endoscope Assisted Endotracheal Intubation [EAE]

Comparison of standard endotracheal intubation and endoscopist-facilitated endotracheal intubation

Read the detailed description

Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures are typically performed using general anesthesia. During anesthesia, the anesthesiologist inserts a breathing tube (endotracheal tube) into the patient's wind pipe (trachea) and a machine helps the patient breathe (mechanical ventilation) while they are unconscious. The breathing tube is inserted with a patient laying on his/her back using a rigid metallic device (laryngoscope) to guide tube placement. The unconscious patient is then moved from the portable bed onto the X-ray table by nursing staff. The patient also has to be turned to lie on their stomach on the X-ray table for the procedure. This standard approach carries a small risk of patient injury during breathing tube placement as well as while moving and turning the unconscious patient onto the X-ray table.

At our endoscopy unit, endoscopists have, on several occasions, used a slim gastroscope to place the breathing tube under direct visualization in patients who are already positioned on their stomach for ERCP. This approach is rapid and has been uniformly successful and safe.

We hypothesize that this endoscopist-facilitated intubation approach may expedite the procedure and minimize ergonomic strain for staff during patient repositioning while minimizing patient injury during breathing tube placement and repositioning. This study seeks to formally compares the two approaches for placement of a breathing tube.

Being tested
Endoscope assisted endotracheal intubation [EAEI]
Keywords
ERCP, Endoscopic Procedures, Anesthesia
Medical subject headings
Biliary Tract Diseases, Pancreatic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscope assisted endotracheal intubation [EAEI]Procedure or surgery

    Also called Standard Endotracheal Intubation [SEI]

    Endoscope assisted endotracheal intubation [EAEI] performed by anesthesiologist with endoscopist assistance.

Study groups in NCT03879720
Study groupRoleWhat they receive
Standard Endotracheal Intubation (SEI)Active comparatorthe patient will be positioned supine on the gurney for intubation, with eventual position in the standard semi-prone ERCP position on the fluoroscopy table. Anesthesiologist-determined doses of Fentanyl, Versed, Propofol and Succinylcholine will be administered per standard of care and intubation will be accomplished by direct laryngoscopy or glidescope, with confirmation of endotracheal tube placement by auscultation.
Receives: Procedure: Endoscope assisted endotracheal intubation [EAEI]
Endoscope assisted endotracheal intubation [EAEI]Experimentalthe patients will position themselves in the semi-prone position on the fluoroscopy table. Anesthesiologist-determined doses of Fentanyl, Versed and Propofol will be administered per standard of care. Succinylcholine will not be administered and therefore the patient will not be paralyzed. The endotracheal tube will be positioned on the mid-distal aspect of the ultra-slim endoscope and the ultra-slim endoscope will then be advanced into the trachea under direct endoscopic visualization to the level of the carina. The anesthesiologist will then advance the endotracheal tube over the endoscope into the trachea, and its position above the carina will be simultaneously confirmed endoscopically with the ultra-slim endoscope.
Receives: Procedure: Endoscope assisted endotracheal intubation [EAEI]

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Procedure Start

    Time from patient entry into procedure room to insertion of endoscope/start of procedure

    Measured: up to 1 hour

Secondary outcomes (9)
  1. Intubation Time (time from 'ready to intubate', to 'tube confirmation')

    Endoscopy documentation

    Measured: up to 1 hour

  2. Patient positioning time

    Recorded in endoscopy suite

    Measured: up to 1 hour

  3. Staff required for patient positioning

    Recorded in endoscopy suite, # of staff

    Measured: up to 20 minutes

  4. Staff survey/assessment of ergonomic strain

    Staff reporting of ergonomic strain encountered during the procedure scale of 1-5 to rate ergonomic strain,

    Measured: up to 1 hour

  5. Need for special positioning equipment

    Documented based on procedure room observation, list of equipment

    Measured: up to 20 minutes

  6. Hypoxia (nadir O2 sat and duration), Arrhythmia, Hypotension

    Evaluation of hypoxia during intubation

    Measured: up to 20 minutes

  7. Time from removal of GI endoscope to exit from procedure room

    Documented in endoscopy suite

    Measured: up to 60 minutes

  8. Tooth/oropharyngeal trauma, skin/musculoskeletal trauma

    Evaluation of oropharyngeal trauma and skin/musculoskeletal complaints following intubation, rating scale (0-5 to rate damage)

    Measured: up to 24 hours post-procedure

  9. Materials and facility fees

    assessment of cost associated with procedures

    Measured: up to 24 hours post-procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2019
  2. Study start30 Aug 2018
  3. Primary completionOct 2020 (estimated)
  4. Study completionDec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomization to standard endotracheal intubation or endoscopist-facilitated endotracheal intubation.
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03879720
Sponsor's protocol ID
47089
Status last verified
Nov 2019
First submitted
8 Mar 2019
Last updated
8 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Barakat MT, Angelotti T, Ghosh S, Banerjee S. Prospective randomized comparison of endoscopist-facilitated endotracheal intubation and standard intubation for ERCP. Gastrointest Endosc. 2023 Sep;98(3):441-447. doi: 10.1016/j.gie.2023.02.032. Epub 2023 Mar 5.

    PubMed 36878302

Questions about this trial

What is this clinical trial studying?

A study testing Endoscope assisted endotracheal intubation [EAEI] in people with Biliary Tract Diseases and Pancreatic Diseases, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Subhas Banerjee (650-723-2623, sbanerje@stanford.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Procedure Start (time frame: up to 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03879720, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2019; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in